(<-)

[../2006-11]

[../2007-01]

(->)

2006 / December
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
-1- -2-
humblness
-3- -4- -5- -6- -7- -8- -9-
-10- -11- -12- -13- -14- -15- -16-
-17- -18- -19- -20- -21- -22- -23-
랩송년회
-24- -25- -26- -27- -28- -29- -30-
-31-

2006-12-29

{{| 저는 '간절하면 이루어진다'는 속설을 진심으로 믿는 쪽입니다.

(중략)

송구(送舊)의 길목에서 문득 내 간절한 소망은 무엇인가를 생각합니다.

새해에는 더욱 간절해지시길... -정혜신- |}}

2006-12-28

2006-12-27

2006-12-15

{{| "The ultimate goal is to develop reliable and inexpensive detection and imaging products that can be used in a doctor’s office or possibly even at home as part of a regular exam," said Steve Hranilovic, assistant professor of electrical and computer engineering at McMaster. "This would address wait-time and cost issues associated with MRI, CT and other imaging facilities. It would also reduce the misdiagnosis and uncertainty associated with self-examinations." |}}

2006-12-14

2006-12-13

{{| "Often, the fat-free version is not much lower calorie than the regular version," Wansink said. "Low-fat labels trick people into eating more than regular labels. But the cruel twist is that these labels have an even more dramatic impact on those who are overweight. They are at danger for really overindulging when they see something with a low-fat label. If we are looking for an excuse to eat, low-fat labels give it to us." |}}

{{| Monoclonal antibodies’ ability to target a single specific protein on cancer cells, has led to their being called a “magic bullet” that targets only cancer cells while minimizing collateral damage to healthy tissue. That damage causes the toxicity associated with chemotherapy and radiation therapy. In the nearly 20 years since scientists were able to create monoclonal antibodies that could be safely used in humans, eight monoclonal antibodies have been approved for use in clinical treatments to trigger immune responses to cancer cells, modulate cancer cell growth, and deliver drugs to cancer cells. Of these, only three are used on solid tumors. However, solid tumors account for 85 percent of all cancers. |}}

2006-12-11

{{| The antibody, named JAA-F11, targets a particular disaccharide, an antigen known as TF-Ag, which aids the adhesion and spread of certain cancer cells. While the antibody did not kill the cancer cells, it blocked stages of cancer-cell growth that allow the cells to adhere to organ tissue, the research showed. |}}

2006-12-05

{{| Using a variety of sophisticated laboratory techniques, Spencer and his colleagues found that Akt1 "was in fact essential for dendritic cell survival," he said. Then they sought to develop a more potent form of Akt1 that would enable the dendritic cells to live longer, boosting immune response. |}}

2006-12-01

{{| In the first experiments of their kind, researchers at Rice University and The University of Texas M. D. Anderson Cancer Center have determined that carbon nanotubes injected directly into the bloodstream of research lab animals cause no immediate adverse health effects and circulate for more than one hour before they are removed by the liver. |}}

(<-)

[../2006-11]

[../2007-01]

(->)

terra19/2006-12 (last edited 2011-08-03 11:00:38 by localhost)